| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.010 | None | < 0.001 | 1 | 1 | 2016 | 2016 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
homeostatic iron regulator | 0.436 | 0.846 | 2.6E-08 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2005 | 2005 | ||||||||
|
carboxyl ester lipase | 0.514 | 0.808 | 1.5E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.040 | None | 0.500 | 4 | 0 | 1997 | 2019 | ||||||||
|
mevalonate diphosphate decarboxylase | 0.568 | 0.769 | 2.7E-17 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2006 | 2008 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.020 | None | 0.500 | 2 | 1 | 2015 | 2015 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 2 | 0.434 | 0.808 | 0.88 |
|
disease | 0.070 | None | 0.571 | 7 | 1 | 2010 | 2018 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
disease | 0.050 | None | 0.600 | 5 | 1 | 2010 | 2018 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2009 | 2017 | ||||||||
|
Cbl proto-oncogene | 0.527 | 0.769 | 6.1E-04 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2012 | 2012 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2016 | 2018 | ||||||||
|
erythropoietin receptor | 0.526 | 0.692 | 1.0E-02 |
|
disease | 0.080 | None | 0.750 | 8 | 0 | 1994 | 2012 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2007 | 2019 | ||||||||
|
basal cell adhesion molecule (Lutheran blood group) | 0.666 | 0.462 | 1.1E-08 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2007 | 2013 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
disease | 0.090 | None | 0.778 | 9 | 0 | 2011 | 2018 | ||||||||
|
serine and arginine rich splicing factor 2 | 0.561 | 0.731 | 0.48 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2016 | 2018 | ||||||||
|
nuclear factor, erythroid 2 | 0.628 | 0.577 | 0.67 |
|
disease | 0.070 | None | 0.857 | 7 | 1 | 2005 | 2014 | ||||||||
|
calreticulin | 0.413 | 0.923 | 0.89 |
|
disease | 0.100 | None | 0.885 | 26 | 0 | 2013 | 2019 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
disease | 0.400 | None | 0.900 | 10 | 0 | 2009 | 2018 | ||||||||
|
CD177 molecule | 0.595 | 0.654 |
|
disease | 0.100 | None | 0.917 | 24 | 0 | 2000 | 2008 | |||||||||
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
disease | 0.400 | None | 0.923 | 24 | 3 | 1995 | 2019 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.100 | None | 0.941 | 16 | 0 | 1996 | 2019 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 1.000 | None | 0.975 | 425 | 9 | 2005 | 2020 | ||||||||
|
erythropoietin | 0.381 | 0.885 | 1.1E-02 |
|
disease | 0.100 | None | 1.000 | 46 | 0 | 1983 | 2020 |